홈 › 유방암 › 코네티컷 › Bridgeport
CT Bridgeport의 유방암 임상 시험
유방암 관련 연구 21개가 Bridgeport 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Stony Brook University Medical Center, Stony Brook · 18마일 거리
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
피험자 모집 중3상
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18마일 거리
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
피험자 모집 중3상
- Research Site, Stony Brook · 18마일 거리
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
피험자 모집 중3상
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4마일 거리
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5마일 거리
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
피험자 모집 중
- Stony Brook Cancer Center, Stony Brook · 18마일 거리
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
피험자 모집 중1/2상
- Stony Brook University Hospital, Stony Brook · 18마일 거리
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
피험자 모집 중3상
- Stony Brook University Medical Center, Stony Brook · 18마일 거리
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
피험자 모집 중3상
- Stony Brook University Cancer Center, Stony Brook · 18마일 거리
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
피험자 모집 중3상
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19마일 거리
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19마일 거리
- New York Cancers & Blood Specialists, Port Jefferson Station · 19마일 거리
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
피험자 모집 중3상
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4마일 거리
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5마일 거리
- 외 1개
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
피험자 모집 중2상
- Stony Brook Cancer Center, Stony Brook · 18마일 거리
ATEMPT 2.0: Adjuvant T-DM1 vs TH
피험자 모집 중2상
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4마일 거리
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5마일 거리
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
피험자 모집 중1상
- New York Cancer and Blood Specialists, Port Jefferson Station · 19마일 거리
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
피험자 모집 중3상
- Stony Brook University Cancer Center, Stony Brook · 18마일 거리
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
피험자 모집 중3상
- Smilow Cancer Hospital - Fairfield, Fairfield · 5마일 거리
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
피험자 모집 중3상
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4마일 거리
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5마일 거리
- Stony Brook University Medical Center, Stony Brook · 18마일 거리
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
피험자 모집 중관찰 연구
- Stony Brook Medicine, Stony Brook · 18마일 거리
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
피험자 모집 중초기 1상
- Stony Brook Breast Center, Stony Brook · 18마일 거리
Definitive Radiation Therapy for Inoperable Breast Cancer
피험자 모집 중
- Stony Brook University Cancer Center, Stony Brook · 18마일 거리
Definitive Radiation for High-Risk Spine Metastases
피험자 모집 중2상
- Stony Brook University Hospital, Stony Brook · 18마일 거리
CtDNA Based MRD Testing for NAC Monitoring in TNBC
피험자 모집 중관찰 연구
- Stony Brook University Cancer Center, Stony Brook · 18마일 거리
다른 도시의 유방암 시험
- New York City, NY연구 136개
- Houston, TX연구 126개
- Boston, MA연구 112개
- Nashville, TN연구 81개
- Los Angeles, CA연구 73개
- Edison, NJ연구 68개
- St. Louis, MO연구 64개
- Queens, NY연구 64개
- Durham, NC연구 64개
- Chicago, IL연구 59개
- Philadelphia, PA연구 56개
- Dallas, TX연구 55개
Bridgeport의 다른 연구
- 비소세포폐암연구 14개
- 폐암연구 13개
- 급성 골수성 백혈병연구 12개
- 심혈관 질환연구 9개
- 암 (전체)연구 8개
- 두경부 편평세포암연구 8개
- 전이성 암연구 7개
- 심부전연구 7개
- 뇌동맥류연구 6개
- 다발성 골수종연구 6개
- 전립선암연구 6개
- 난소암연구 5개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.